AstraZeneca’s Kelly Teasdale joins Burson-Marsteller
Kelly Teasdale has joined Burson-Marsteller’s healthcare team as senior director, following two years as global brand comms director at pharmaceutical firm AstraZeneca.
Kelly Teasdale
At AstraZeneca, Teasdale developed global comms strategies for oncology and cardiovascular-focused products, supported global corporate brand comms and led patient advocacy and patient-centric strategy.
Before AstraZeneca, Teasdale was global MD and partner at health and well-being agency TogoRun, where she worked for clients including L’Oreal.
She has also held roles at Chandler Chicco Companies Europe and Weber Shandwick.
In her new role at Burson-Marsteller, which she starts today, Teasdale will work on a range of global comms accounts, focusing on leading brands and pipeline assets.
Kate Hawker, MD and UK and EMEA healthcare lead at Burson-Marsteller, said: “Kelly is an outstanding global healthcare communications lead and her experience will really help us to develop our capability in key growth areas for us, such as patient centricity and advocacy.”
Teasdale added: “I have always been impressed by the calibre of the Burson-Marsteller team and their commitment to evidence based communications and creative thinking has tempted me back into agency life. I am delighted to be joining the expanding healthcare team in London to devise and deliver industry leading campaigns on behalf of our clients.”
